Product Information
OXYBUTYNIN 5 MG TABLET is a generic product labeled by Leading Pharma, LLC, priced at $0.0473 per EA under NDC 69315018205. Its NADAC has been published 248 times since Sep 29, 2021.
Strength
5 mg/1
Manufacturer
Leading Pharma, LLCNDC
69315018205
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
OXYBUTYNIN CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA212798On Market Since
11/1/2019
Pharmacological Classes
Price Statistics
The NADAC for OXYBUTYNIN 5 MG TABLET has been published 248 times since Sep 29, 2021, and over the history we have for it it has declined 37.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0473 per EA |
|---|---|
| All-time high | $0.0786 (Apr 13, 2022) |
| All-time low | $0.0448 (Nov 20, 2024) |
| 52-week high | $0.0505 |
| 52-week low | $0.0455 |
| Median price | $0.0594 |
| Average price | $0.0593 |
| Largest weekly change | -28.1% (Apr 17, 2024) |
| Weeks tracked | 248 |
| Tracking since | Sep 29, 2021 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of OXYBUTYNIN 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXYBUTYNIN 5 MG TABLET, manufactured by Leading Pharma, LLC, is $0.0473 per EA (NDC 69315018205), effective Jun 24, 2026.
How has the price of OXYBUTYNIN 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXYBUTYNIN 5 MG TABLET has declined 37.9%. It has been tracked across 248 weekly CMS publications since Sep 29, 2021.
What are the highest and lowest recorded NADAC prices for OXYBUTYNIN 5 MG TABLET?
Since Sep 29, 2021, the NADAC for OXYBUTYNIN 5 MG TABLET has ranged from a low of $0.0448 (Nov 20, 2024) to a high of $0.0786 (Apr 13, 2022), with a median of $0.0594 per EA.
Are there cheaper alternatives to OXYBUTYNIN 5 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as OXYBUTYNIN 5 MG TABLET, but none are currently priced below it.
Who manufactures OXYBUTYNIN 5 MG TABLET?
OXYBUTYNIN 5 MG TABLET (NDC 69315018205) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification